What does it mean for society when fewer children are born, and more people struggle to become parents?
In this episode of BusinessReview Life Science, we focus on involuntary infertility – a growing challenge with significant personal and societal consequences.
The panel discusses everything from delayed fertility and lack of awareness about male infertility to the limited research in the field.
We also take a closer look at ReproUnion and the RUBIC biobank – groundbreaking initiatives that bring together researchers and healthcare professionals across the Øresund region to generate new knowledge and improve treatments.
This podcast contains sponsored content
Guests:
Kelle Moley, Vice President, Reproductive Medicine and Maternal Health, Ferring Pharmaceuticals
Anette Steenberg, CEO, Medicon Valley Alliance
Eva Hoffmann, Professor of Functional Genomics & Reproductive Health, University of Copenhagen
Host:
Søren Vejby
Production:
Martin Andersen
...................................
Hvad betyder det for samfundet, når færre børn bliver født, og flere kæmper for at blive forældre?
I dette afsnit af BusinessReview Life Science stiller vi skarpt på ufrivillig barnløshed – en voksende udfordring med store menneskelige og samfundsmæssige konsekvenser.
Panelet diskuterer alt fra sen fertilitet og manglende viden om mandlig infertilitet til den begrænsede forskning på området.
Vi ser også nærmere på ReproUnion og biobanken RUBIC – banebrydende initiativer, der samler forskere og sundhedsaktører på tværs af Øresund for at skabe ny viden og bedre behandlinger.
Podcasten har sponsoreret indhold
Gæster:
Kelle Moley, Vice President, Reproductive Medicine And Maternal Health at Ferring Pharmaceuticals
Anette Steenberg, CEO, Medicon Valley Alliance
Eva Hoffmann, Professor of Functional Genomics & Reproductive Health, University of Copenhagen
Vært:
Søren Vejby
Produktion:
Martin Andersen
